Antibiotice S.A. (BVB:ATB)
Romania · Delayed Price · Currency is RON 1.940
+0.004 (0.21%)
At close: Sep 2, 2026
Antibiotice Revenue
Antibiotice had revenue of 164.90M RON in the quarter ending June 30, 2026, a decrease of -4.70%. This brings the company's revenue in the last twelve months to 616.58M, down -6.43% year-over-year. In the year 2025, Antibiotice had annual revenue of 647.25M, down -4.48%.
Revenue (ttm)
616.58M
Revenue Growth
-6.43%
P/S Ratio
2.11
Revenue / Employee
455.04K
Employees
1,356
Market Cap
1.30B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 647.25M | -30.33M | -4.48% |
| Dec 31, 2024 | 677.58M | 62.29M | 10.12% |
| Dec 31, 2023 | 615.29M | 124.07M | 25.26% |
| Dec 31, 2022 | 491.22M | 122.94M | 33.38% |
| Dec 31, 2021 | 368.28M | 27.41M | 8.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Alro S.A. | 4.30B |
| Sphera Franchise Group | 1.59B |
| Teraplast | 1.11B |
| Chimcomplex | 1.00B |
| Fondul Proprietatea | 671.33M |
| TTS (Transport Trade Services) | 656.70M |
| Biofarm | 294.25M |
| Infinity Capital Investments | 277.14M |